US Stock MarketDetailed Quotes
TNON Tenon Medical
- 2.340
- -0.060-2.50%
Close Nov 27 16:00 ET
- 2.310
- -0.030-1.28%
Post 20:01 ET
7.34MMarket Cap-96P/E (TTM)
2.370High2.200Low173.40KVolume2.330Open2.400Pre Close396.04KTurnover5.62%Turnover RatioLossP/E (Static)3.14MShares18.00052wk High1.65P/B7.22MFloat Cap2.20052wk Low--Dividend TTM3.08MShs Float4791.200Historical High--Div YieldTTM7.08%Amplitude2.200Historical Low2.283Avg Price1Lot Size
Tenon Medical Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 25.69%-2.34M | 23.80%-2.42M | 34.62%-2.34M | -1.31%-12.18M | 32.70%-2.28M | 7.62%-3.15M | -14.95%-3.18M | -45.13%-3.58M | -180.17%-12.03M | -100.30%-3.39M |
| Net income from continuing operations | 4.44%-3.18M | 10.71%-3.83M | 25.96%-3.58M | 17.63%-15.58M | 60.35%-3.13M | -5.08%-3.33M | 21.92%-4.29M | -105.27%-4.83M | -167.15%-18.92M | -178.15%-7.91M |
| Depreciation and amortization | 57.69%164K | 64.84%150K | 100.00%160K | 47.40%426K | 91.14%151K | 33.33%104K | 28.17%91K | 31.15%80K | 153.51%289K | 54.90%79K |
| Other non cash items | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 4.06%1.92M | --0 |
| Change In working capital | 76.58%-233K | 616.67%186K | -62.69%50K | -168.12%-1.17M | -108.62%-276K | 24.45%-995K | -107.95%-36K | 121.79%134K | 280.97%1.72M | 1,228.22%3.2M |
| -Change in receivables | -14.53%-197K | 49.47%-144K | 28.41%-63K | -90.79%-290K | 403.57%255K | -149.28%-172K | -2,750.00%-285K | -900.00%-88K | -149.18%-152K | -1,580.00%-84K |
| -Change in inventory | -97.92%2K | 114.94%23K | -7,700.00%-78K | 38.77%-139K | -120.25%-80K | 152.75%96K | -492.31%-154K | 99.76%-1K | -56.55%-227K | 337.95%395K |
| -Change in prepaid assets | 323.53%288K | -104.78%-471K | 130.53%29K | -428.07%-301K | -202.33%-44K | 278.95%68K | -243.28%-230K | -2,000.00%-95K | 56.15%-57K | 4,400.00%43K |
| -Change in payables and accrued expense | 71.98%-260K | 22.09%840K | -40.05%223K | -109.15%-216K | -112.00%-348K | 5.02%-928K | 13.72%688K | 320.12%372K | 171.26%2.36M | 530.65%2.9M |
| -Change in other current liabilities | -11.86%-66K | -12.73%-62K | -12.96%-61K | -12.38%-227K | -9.26%-59K | -15.69%-59K | -12.24%-55K | -12.50%-54K | -146.34%-202K | -14.89%-54K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 25.69%-2.34M | 23.80%-2.42M | 34.62%-2.34M | -1.31%-12.18M | 32.70%-2.28M | 7.62%-3.15M | -14.95%-3.18M | -45.13%-3.58M | -180.17%-12.03M | -100.30%-3.39M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -123.85%-104K | 0 | -102.55%-119K | 312.97%6.14M | -103.93%-92K | 133.11%436K | 113.80%1.13M | 9.19%4.67M | 35.97%-2.88M | -30.70%2.34M |
| Net PPE purchase and sale | -82.46%-104K | --0 | -41.67%-119K | 57.38%-361K | 84.69%-92K | 25.97%-57K | -212.20%-128K | 34.38%-84K | -730.39%-847K | -615.48%-601K |
| Net investment purchase and sale | --0 | --0 | --0 | 419.24%6.5M | --0 | 139.76%493K | 115.44%1.26M | 7.92%4.75M | 53.73%-2.04M | -15.00%2.94M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -123.85%-104K | --0 | -102.55%-119K | 312.97%6.14M | -103.93%-92K | 133.11%436K | 113.80%1.13M | 9.19%4.67M | 35.97%-2.88M | -30.70%2.34M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 3,524.44%9.64M | 0 | 10,507.14%4.37M | -55.35%6.3M | 5,584.00%1.37M | 266K | -66.84%4.71M | 22.22%-42K | 23.06%14.11M | 86.03%-25K |
| Net issuance payments of debt | ---- | ---- | ---- | --1.25M | ---- | ---- | ---- | ---- | --0 | ---- |
| Net common stock issuance | 790.51%4.03M | --0 | --1.93M | -62.49%5.3M | --42K | --453K | --4.81M | --0 | --14.14M | --0 |
| Net preferred stock issuance | --489K | --0 | --2.44M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Proceeds from stock option exercised by employees | ---- | ---- | ---- | --258K | --258K | ---- | ---- | ---- | --0 | ---- |
| Net other financing activities | ---- | ---- | ---- | -1,936.00%-509K | ---179K | ---187K | ---101K | 22.22%-42K | 93.02%-25K | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 3,524.44%9.64M | --0 | 10,507.14%4.37M | -55.35%6.3M | 5,584.00%1.37M | --266K | -66.84%4.71M | 22.22%-42K | 23.06%14.11M | 86.03%-25K |
| Net cash flow | ||||||||||
| Beginning cash position | -66.37%1.97M | 38.03%4.39M | 14.04%2.43M | -27.01%2.13M | 6.91%3.37M | -25.69%5.85M | -32.03%3.18M | -27.01%2.13M | 1,085.77%2.92M | 123.78%3.15M |
| Current changes in cash | 393.51%7.19M | -190.98%-2.42M | 82.11%1.91M | 132.83%261K | 6.72%-999K | 48.18%-2.45M | -18.10%2.66M | -40.22%1.05M | -129.74%-795K | -171.16%-1.07M |
| Effect of exchange rate changes | --0 | --0 | 4,700.00%46K | 442.86%38K | 19.15%56K | -475.00%-30K | 126.00%13K | -150.00%-1K | 450.00%7K | 2,250.00%47K |
| End cash Position | 171.79%9.16M | -66.37%1.97M | 38.03%4.39M | 14.04%2.43M | 14.04%2.43M | 6.91%3.37M | -25.69%5.85M | -32.03%3.18M | -27.01%2.13M | -27.01%2.13M |
| Free cash flow | 23.77%-2.45M | 26.76%-2.42M | 32.87%-2.46M | 2.55%-12.54M | 40.54%-2.37M | 8.02%-3.21M | -17.83%-3.3M | -41.20%-3.66M | -192.94%-12.87M | -124.69%-3.99M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data